Stage III Ovarian Epithelial Cancer Completed Phase 2 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs